WEDNESDAY, April 22, 2020 (HealthDay News) — As researchers hunt for strategies to deal with critical COVID-19 infections, a new demo will inquire whether or not an previous arthritis drug can avert really serious issues in the very first place.
The medicine, known as colchicine, is an oral anti-inflammatory that has lengthy been approved for gout, a kind of arthritis. Its history goes back thousands of several years, and the drug was very first sourced from the autumn crocus flower.
Medical practitioners also sometimes use colchicine to deal with pericarditis, the place the sac all-around the heart will become inflamed.
Now researchers in the United States and Canada are screening it for a various function: Maintaining high-danger COVID-19 patients from finding ill plenty of to land in the hospital.
Colchicine is just one of a number of anti-inflammatory medicine presently in clinical trials for dealing